Commentary

Ensuring product integrity and security throughout the supply chain has always been a top priority for biopharmaceutical manufacturers. However, a convergence of new forces — intense cost pressure and competition, a changing product portfolio, stricter regulations, rapid growth in emerging markets and increasing risk — is raising the stakes significantly.
The 18th Annual TPM Conference marks the start of formal negotiations between many beneficial cargo owners and container lines on annual trans-Pacific service contracts. Price, as always, will drive those negotiations. However, as recent news demonstrates, price is not everything.